Elan Extends Tysabri's Reach
Motley Fool - USA
... ELN) and partner Biogen Idec (Nasdaq: BIIB) have been diligently attempting to gain approval for the companies' multiple sclerosis product, Tysabri, in some of ...
See all stories on this topic

Health Canada Grants Approval of Biogen Idec’s TYSABRI(TM) and ...
Financial News USA (press release) - La Puente,CA,USA
... Canada and Elan Corporation, plc announced recently that following a priority review process, Health Canada has granted approval to TYSABRI(TM) (natalizumab ...